FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 3223492 · Received July 12, 2013

Report

Report Number
2124215-2013-10469
Event Type
Malfunction
Date Received
July 12, 2013
Date of Event
June 12, 2013
Report Date
June 12, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT HIGH SHOCK IMPEDANCE MEASUREMENTS WERE OBSERVED ON THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) AND RIGHT VENTRICULAR (RV) LEAD THROUGH THE REMOTE MONITORING SYSTEM. ADDITIONAL INFORMATION INDICATED THAT ALL OTHER MEASUREMENTS WERE NORMAL AND THAT NO INTERVENTION WAS PLANNED AT THIS TIME. THE PHYSICIAN WAS GOING TO CONTINUE MONITORING THE PATIENT THROUGH THE REMOTE MONITORING SYSTEM. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE DEVICE AND LEAD REMAINS IN SERVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
321615 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND F103

Patients

Seq Age Sex Outcome Treatment
1